Impact of Employee Health Promotion Course on Health Promotion in the Work Place.

NCT03295136 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2023-04-25

No results posted yet for this study

Summary

People of working age spend most of their day at work, and usually have less time to participate in other activities, the work day in Israel being one of the longest in the OECD. Work places, therefore, present the most suitable setting for health interventions, as they are an accessible and available framework and have real potential of creating change.

The current Health Promotion in the Work Place training course aims to train female employees to design, implement, and evaluate a health promotion program in their workplace, as well as promote personal change in improving healthy habits, and empowering the participants. A unique course has been designed, consisting of 20 sessions- 15 consecutive sessions, and 5 maintenance sessions throughout the year. The course will focus on acquiring health knowledge and health promotion skills, as well as leadership skills and empowerment.

Conditions

  • Lifestyle Risk Reduction
  • Health Knowledge, Attitudes, Practice
  • Empowerment

Interventions

BEHAVIORAL

Health Promotion Training for Women Employees

Group intervention over a one year, acquiring health promotion tools and skills, as well as leadership and project designing and implementation skills.

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Donna R Zwas, MD · Hadassah Medical Organization

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03295136 on ClinicalTrials.gov